Medicament Surgipharm LLP

Olimab 60 mg Injection contains Denosumab, a monoclonal antibody used in the treatment of osteoporosis and bone loss in patients at high risk of fractures. It works by reducing bone breakdown and increasing bone strength, helping prevent fractures in postmenopausal women, men with osteoporosis, and patients undergoing certain cancer treatments that weaken bones.

This injection is given subcutaneously under the supervision of a healthcare professional, usually once every 6 months. Olimab 60 mg is widely prescribed for its proven efficacy, safety, and long-term bone protection.

Key Features & Benefits:

• Brand: Olimab 60 mg Injection

• Composition: Denosumab 60 mg

• Used for osteoporosis and bone loss treatment

• Helps in preventing fractures & increasing bone density

• Administered as a subcutaneous injection every 6 months

• For clinical & hospital use under medical supervision